Nikos Evangelou Selected Research

Nikos Evangelou Research Topics

22	Multiple Sclerosis 04/2024 - 01/2013
6	COVID-19 01/2023 - 07/2021
5	Infections 02/2024 - 07/2021
3	Relapsing-Remitting Multiple Sclerosis 09/2023 - 01/2013
3	Demyelinating Diseases (Demyelinating Disease) 04/2014 - 07/2006
2	Optic Neuritis (Retrobulbar Neuritis) 01/2019 - 11/2015
2	Neuromyelitis Optica (Devic's Disease) 04/2014 - 01/2009
1	Lymphopenia (Lymphocytopenia) 02/2024
1	Chronic Progressive Multiple Sclerosis 02/2024
1	Vitamin B 12 Deficiency (Vitamin B12 Deficiency) 06/2023
1	Subacute Combined Degeneration 06/2023
1	Cognitive Dysfunction 01/2023
1	Brain Concussion (Cerebral Concussion) 01/2021
1	Pulmonary Embolism 01/2020
1	Venous Thromboembolism 01/2020
1	Vascular Diseases (Vascular Disease) 01/2018
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2016
1	Lymphomatoid Papulosis 01/2016
1	Inflammation (Inflammations) 11/2015
1	Ocular Motility Disorders (Convergence Insufficiency) 01/2009

5	VaccinesIBA 03/2023 - 01/2022
4	Biomarkers (Surrogate Marker)IBA 12/2022 - 05/2013
4	Fingolimod Hydrochloride (FTY720)FDA Link 08/2022 - 01/2013
3	COVID-19 VaccinesIBA 01/2023 - 01/2022
2	Amiloride (Midamor)FDA LinkGeneric 01/2019 - 11/2015
1	siponimodIBA 02/2024
1	Nitrous Oxide (Laughing Gas)IBA 06/2023
1	Sphingosine-1-Phosphate ReceptorsIBA 03/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	IronIBA 12/2022
1	ocrelizumabIBA 01/2022
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2022
1	insulin receptor-related receptor (IRR)IBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2021
1	Dimethyl FumarateIBA 01/2020
1	Retinaldehyde (Retinal)IBA 01/2019
1	Acid Sensing Ion ChannelsIBA 01/2019
1	anti-aquaporin 4 autoantibodyIBA 01/2018
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2018
1	A 7 (A-7)IBA 11/2016
1	AntibodiesIBA 04/2014
1	Natalizumab (Tysabri)FDA Link 04/2014
1	Immunomodulating AgentsIBA 04/2014
1	teriflunomideIBA 01/2013
1	GadoliniumIBA 01/2009
1	Proteins (Proteins, Gene)FDA Link 07/2006
1	Myelin ProteinsIBA 07/2006

12	Therapeutics 04/2024 - 04/2013
1	Injections 09/2023
1	Activities of Daily Living (ADL) 01/2023
1	Cognitive Training 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2015